These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38150333)
1. Development of 2-Aminotetralin-Type Serotonin 5-HT McGlynn RP; Cui M; Brems B; Holbrook O; Booth RG ACS Chem Neurosci; 2024 Jan; 15(2):357-370. PubMed ID: 38150333 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714 [TBL] [Abstract][Full Text] [Related]
3. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes. Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787 [TBL] [Abstract][Full Text] [Related]
4. Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT Edvinsson JCA; Maddahi A; Christiansen IM; Reducha PV; Warfvinge K; Sheykhzade M; Edvinsson L; Haanes KA J Headache Pain; 2022 Feb; 23(1):26. PubMed ID: 35177004 [TBL] [Abstract][Full Text] [Related]
5. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue. Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351 [TBL] [Abstract][Full Text] [Related]
6. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist. Doménech T; Beleta J; Palacios JM Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):328-34. PubMed ID: 9303569 [TBL] [Abstract][Full Text] [Related]
7. Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [35S]GTPgammaS binding responses. Dupuis DS; Perez M; Halazy S; Colpaert FC; Pauwels PJ Brain Res Mol Brain Res; 1999 Apr; 67(1):107-23. PubMed ID: 10101238 [TBL] [Abstract][Full Text] [Related]
8. Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors. Newman-Tancredi A; Cussac D; Audinot V; Millan MJ Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):447-53. PubMed ID: 10431754 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT Perry CK; Casey AB; Felsing DE; Vemula R; Zaka M; Herrington NB; Cui M; Kellogg GE; Canal CE; Booth RG Bioorg Med Chem; 2020 Feb; 28(3):115262. PubMed ID: 31882369 [TBL] [Abstract][Full Text] [Related]
10. 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies. Piñeyro G; de Montigny C; Blier P Neuropsychopharmacology; 1995 Nov; 13(3):249-60. PubMed ID: 8602897 [TBL] [Abstract][Full Text] [Related]
11. The role of peripheral 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E and 5-HT1F serotonergic receptors in the reduction of nociception in rats. Granados-Soto V; Argüelles CF; Rocha-González HI; Godínez-Chaparro B; Flores-Murrieta FJ; Villalón CM Neuroscience; 2010 Jan; 165(2):561-8. PubMed ID: 19837141 [TBL] [Abstract][Full Text] [Related]
12. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Fabre V; Beaufour C; Evrard A; Rioux A; Hanoun N; Lesch KP; Murphy DL; Lanfumey L; Hamon M; Martres MP Eur J Neurosci; 2000 Jul; 12(7):2299-310. PubMed ID: 10947809 [TBL] [Abstract][Full Text] [Related]
13. Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist? Schoeffter P; Hoyer D Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):675-83. PubMed ID: 2770889 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors. Sánchez-Lopez A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM Br J Pharmacol; 2003 Oct; 140(4):725-35. PubMed ID: 14504136 [TBL] [Abstract][Full Text] [Related]
15. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery. Bouchelet I; Case B; Olivier A; Hamel E Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348 [TBL] [Abstract][Full Text] [Related]
16. Cultured astrocytes express messenger RNA for multiple serotonin receptor subtypes, without functional coupling of 5-HT1 receptor subtypes to adenylyl cyclase. Hirst WD; Cheung NY; Rattray M; Price GW; Wilkin GP Brain Res Mol Brain Res; 1998 Oct; 61(1-2):90-9. PubMed ID: 9795156 [TBL] [Abstract][Full Text] [Related]
17. Unravelling the pharmacological profile of the canine external carotid vasodilator '5-HT1-like' receptors: coexistence of sympatho-inhibitory 5-HT1B and postjunctional 5-HT7 receptors. Villalón CM; Sánchez-López A; Centurión D; Saxena PR Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):73-80. PubMed ID: 11191839 [TBL] [Abstract][Full Text] [Related]